Cor Vasa 2022, 64(1):67-71 | DOI: 10.33678/cor.2021.066

(Diagnosis of laminopathy with predominant cardiac involvement during pretransplant assessment - a case report with a review of risk stratification and disease management of laminopathies)

Katarína Hromaníkováa, Miloš Kubáneka, Alice Krebsováa, Petra Peldováb, Pavel Votýpkab, Milan Macekb, Markéta Hegarováa, Vojtěch Melenovskýa, Josef Kautznera
a Klinika kardiologie, Institut klinické a experimentální medicíny, Praha
b Ústav biologie a lékařské genetiky, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice v Motole, Praha

We present a case of laminopathy, which was diagnosed in a sixteen-year-old female patient referred for heart transplant enlistment. In addition to advanced heart failure due to dilated cardiomyopathy, we detected mild contractures of elbow flexors. Molecular genetic analysis revealed a pathogenic variant of lamin A/C LMNA:c.241T>G, p.Tyr81Asp. These findings were compatible with Emery-Dreifuss myopathy with predominant cardiac involvement. Furthermore, we discuss clinical presentation of laminopathy, prognostic stratification of carriers of pathogenic LMNA variants and clinical management of patients with laminopathy.

Keywords: Cardiomyopathy, Emery-Dreifuss myopathy, Laminopathy,

Received: May 23, 2021; Revised: May 23, 2021; Accepted: June 6, 2021; Published: February 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hromaníková K, Kubánek M, Krebsová A, Peldová P, Votýpka P, Macek M, et al.. (Diagnosis of laminopathy with predominant cardiac involvement during pretransplant assessment - a case report with a review of risk stratification and disease management of laminopathies). Cor Vasa. 2022;64(1):67-71. doi: 10.33678/cor.2021.066.
Download citation

References

  1. Taylor MRG, Fain PR, Sinagra G, et al. Natural History of Dilated Cardiomyopathy Due to Lamin A/C Gene Mutations. J Am Coll Cardiol 2003;5:771-780. Go to original source... Go to PubMed...
  2. Van Tintelen JP, Hofstra RMW, Katerberg H, et al. High Yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease reffered to cardiogenetics outpatient clinics. Am Heart J 2007;12:1130-1139. Go to original source... Go to PubMed...
  3. Tesson F, Saj M, Uvaize MM, et al. Lamin A/C mutations in dilated cardiomyopathy. Cardiol J 2014;21:331-342. Go to original source... Go to PubMed...
  4. Feingold B, Mahle WT, Auerbach S, et al. Management of Cardiac Involment Associated With Neuromuscular Diseases. A Scientific Statement From the American Heart Association. Circulation 2017;9:200-231. Go to original source... Go to PubMed...
  5. Heller SA, Shih R, Kalra R, et al. Emery-Dreifuss muscular dystrophy. Muscle Nerve 2020;4:436-448. Go to original source... Go to PubMed...
  6. Haberlová J. Svalové dystrofie v dětském věku. Neurol pro Praxi 2019;20:171-178. Go to original source...
  7. Rapezzi C, Arbustini E, Caforio ALP, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working group on Myocardial and Pericardial Diseases. Eur Heart J 2013;5:1448-1458. Go to original source... Go to PubMed...
  8. Van Rijsingen IAW, Arbustini E, Elliott PM, et al. Risk Factors of Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers. A European Cohort Study. J Am Coll Cardiol 2012;1:493-500. Go to original source... Go to PubMed...
  9. Priori AG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015;36:2793-2867. Go to original source... Go to PubMed...
  10. Wahbi K, Yaou RB, Gandjbakhch E, et al. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. Circulation 2019;140:293-302. Go to original source... Go to PubMed...
  11. Anselme F, Moubarak G, Savouré A, et al. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. Heart Rhythm 2013;10:1492-8. Go to original source... Go to PubMed...
  12. Kumar S, Androulakis AFA, Sellal JM, et al. Multi-center Experience with Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy. Circ Arrhythm Electrophysiol 2016;9:e004357. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.